PITTSBURGH, March 17 /PRNewswire/ -- Cardiorobotics, Inc., a medical device company developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military, and law enforcement, announces the appointment of Dr. Samuel Straface in the position of President & Chief Executive Officer.
"We are excited that Dr. Straface has joined Cardiorobotics in this executive leadership role," stated Executive Chairman and founding CEO, David Wagner. "Dr. Straface's long track record of commercial success, exceptional management, interpersonal and organizational skills, along with a diverse industry background in biological sciences, surgical applications and medical devices will guide Cardiorobotics as we continue to develop into a world class company.
"This appointment reinforces Cardiorobotics' commitment to creating a medical device company that will be a leader in developing products to serve a number of different specialist areas, including: minimally-invasive cardiac surgery, electrophysiology, natural orifice and a range of single-port laparoscopic and thoracoscopic procedures," says Mr. Wagner.
Dr. Straface has joined the leadership team that includes the two company co-founders; Chief Technology Officer Howie Choset, Ph.D. and Chairman of the Scientific Advisory Board, Marco A. Zenati, M.D. "I am excited about joining the Cardiorobotics team and leading them through the company's first clinical trials and then commercialization for single port cardiac procedures," stated Dr. Straface.
Dr. Straface began working with Cardiorobotics as an Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse (PLSG). "We are thrilled that the PLSG is able to assist in the commercialization of Cardiorobotics and help to facilitate the development of the leadership team," says John W. Manzetti, PLSG President & CEO. "Samuel has the back
|SOURCE Pittsburgh Life Sciences Greenhouse|
Copyright©2009 PR Newswire.
All rights reserved